Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells

Neuroreport. 1998 Jun 1;9(8):1749-55. doi: 10.1097/00001756-199806010-00015.

Abstract

The aim of the present study was to determine whether amyloid beta-peptide (A beta) induces mitochondrial dysfunction. Mitochondrial function was reported to be affected following A beta exposure, as demonstrated by depolarization of the mitochondrial membrane, decrease of oxygen consumption and by the inhibition of complexes I, III and IV of the mitochondrial respiratory chain. A beta25-35 and A beta1-40 peptides also inhibited MTT reduction in a dose-dependent manner in undifferentiated and differentiated PC12 cells. Several antioxidants prevented this inhibitory response, suggesting that oxidative stress is involved in A beta-induced cytotoxicity. These data suggest that mitochondrial dysfunction contributes to amyloid beta-protein cytotoxicity and may play a major role in the abnormalities of energy metabolism observed in Alzheimer's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Antioxidants / pharmacology
  • Cell Differentiation / drug effects
  • Cell Survival / drug effects
  • Logistic Models
  • Membrane Potentials / drug effects
  • Mitochondria / drug effects*
  • PC12 Cells
  • Peptide Fragments / pharmacology
  • Rats

Substances

  • Amyloid beta-Peptides
  • Antioxidants
  • Peptide Fragments
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (25-35)